Navigation Links
Kogenate® FS, Antihemophilic Factor (Recombinant), for Hemophilia A Now Easier For People to Store at Home or On The Go
Date:4/25/2011

WAYNE, N.J., April 25, 2011 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved a new storage option for Kogenate® FS, antihemophilic factor (recombinant), now allowing the product to be stored at room temperature (up to 77 degrees F) for up to one year.  Compared with the previous three-month room temperature option, this new storage option for Kogenate FS offers added convenience for patients with hemophilia A and is immediately available to customers.

Factor VIII products are typically stored in the refrigerator and are stable at room temperature for a limited time.  With this new storage option, people who use Kogenate FS may have more flexibility for storing their medication whether they're at home or at school, at work or at play or when traveling. For some, the approval of this new storage option may free up refrigerator space or possibly eliminate the need for a separate "factor fridge."  

"As convenience with medication is important to people with hemophilia A, we're pleased to offer a new storage temperature option, which complements other convenience features, including Grab and Go packaging with BIO-SET®, a compact and complete reconstitution system for Kogenate FS," said Paul Bedard, Vice President/General Manager, Hematology, Bayer HealthCare Pharmaceuticals.  "This new option demonstrates Bayer's ongoing commitment to the hemophilia A community."

The starting date of room temperature storage for Kogenate FS should be clearly recorded on the unopened product carton.  Once stored at room temperature, the product must not be returned to the refrigerator.  The shelf-life then expires after the storage at room temperature (up to 12 months) or the expiration date on the product vial, whichever is earlier.

For additional information on Kogenate® FS, and the new and extended storage capabilities,
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery
2. NephRx Corp. Awarded U.S. Patent for Use of Novel Growth Factor Peptide NX002 in Inflammatory Bowel Disease
3. Novo Nordisk Submits First Recombinant Treatment for Factor XIII Deficiency for U.S. Regulatory Approval
4. Success Factors and Failure Points in Biopharmaceutical Product Launches
5. CSL Behring Marks World Hemophilia Day with Coagulation Factor Donation to World Federation of Hemophilia
6. Inspiration Biopharmaceuticals Demonstrates Non-Inferiority of IB1001, Its Recombinant Factor IX for Hemophilia B
7. EDC Functionality, Ease of Data Entry, and Access to Data All Factors in University of Virginia Cancer Centers Selection of the OnCore Clinical Research Management System
8. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
9. Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
10. Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process
11. Neurocrine Announces Top-Line Results of Corticotropin Releasing Factor Antagonist GSK561679 for Treatment of Major Depressive Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 3, 2015 Redwood ... Broda Technologies Co., Ltd., operating in both the US ... company,s proprietary IntelliGel ® supramolecular hydrogel technology in ... and other ophthalmic therapies. The Broda technology offers many ... is a free-forming liquid and with low concentrations of ...
(Date:7/2/2015)... 2, 2015 Leading organizations have increasingly ... product and market insights in internal market research ... studies, it is essential for executives to fully ... to capture critical business-related insights. According ... Practices, LLC, most benchmarked companies find it impossible ...
(Date:7/2/2015)... CHAPEL HILL, N.C. , July 2, 2015 /PRNewswire/ ... industry. Because of its leading role in educating thought ... the functions that can heavily influence how well a ... to a new study from research and consulting leader ... Medical Affairs leaders need to focus on are early ...
Breaking Medicine Technology:Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2Leveraging Employee Insights to Produce Cutting-Edge Market Research 2Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2
... Texas, Feb. 23, 2012   ULURU Inc. (NYSE ... Goods Certificate has been issued by the Therapeutic Goods ... Commenting on the approval in Australia, Kerry P. ... another important milestone in the worldwide commercialization of Altrazeal®.  ...
... Feb. 23, 2012 A new imaging efficiency ... Medicaid Services (CMS) to reduce CT scans in ... are performing CT scans inappropriately, according to a ... of Emergency Medicine ("Assessment of Medicare,s Imaging ...
Cached Medicine Technology:ULURU Inc. Announces Approval to Market Altrazeal® in Australia 2ULURU Inc. Announces Approval to Market Altrazeal® in Australia 3Government Rule Designed to Limit CT Scans in ERs Is Unreliable, Invalid and Inaccurate, Says ACEP 2
(Date:7/3/2015)... MO (PRWEB) , ... July 03, 2015 , ... Talcum ... website to replace their existing Talcum Powder Cancer Lawsuit Center website. Just as the ... talcum powder lawsuit news , offering timely lawsuit updates and ovarian cancer warning information. ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Every year, One-to-1 ... Train-a-Thon where they provide members of the Red Deer community with free fitness training ... of fitness training, games, food, events and entertainment raised thousands of charity dollars and ...
(Date:7/2/2015)... ... 02, 2015 , ... Following the recent report by JAMA Internal Medicine ... merely overweight Americans, Samir Becic emphatically declared a war on obesity in the United ... Becic said. "We must understand the magnitude of this discovery. For that reason, I ...
(Date:7/2/2015)... ... , ... In 2012, Patrick Achebe realized that the gift of poetry was fully in him, ... his first poem, and three years later he was publishing an entire book of poetry. ... the world. "I have always believed that the best way to lift yourself up, is ...
(Date:7/2/2015)... ... July 02, 2015 , ... Six months ahead of ... cross-country walk to raise awareness and money for the Pulmonary Hypertension Association (PHA). ... at PHA’s headquarters near Washington, D.C. by mid-September. He left Glasgow, Mont. yesterday morning ...
Breaking Medicine News(10 mins):Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3
... than 27 million adults currently suffer from osteoarthritis, which is ... have been unable to diagnose patients with arthritis until they ... By the time these symptoms are present, it is ... to be effective. Now, a research team from the ...
... By Alan Mozes HealthDay Reporter , TUESDAY, May ... restored partial mobility to the hand of a quadriplegic patient. ... bone in his neck, and it was the specific location ... the spine itself. Instead, the team focused on the ...
... Journal of Thoracic Oncology says molecular biomarkers in ... additional predictive technique for lung cancer screening. , Since ... the positive CT screening results were false positive, scientists have ... research focused on a way to determine if the nodules ...
... HealthDay Reporter , TUESDAY, May 15 (HealthDay News) -- Should Americans ... it to determine whether they,re infected with the virus that causes ... plans to debate this question Tuesday, and the answer the panel ... HIV testing. FDA advisory panel recommendations are not binding, but ...
... Alberta provides new insight into treatment patterns for people ... will help physicians improve care strategies for patients provincewide. ... School of Public Health, says the study of more ... step to addressing gaps in care and ensuring that ...
... death rate in older Americans is likely the effect ... from the Johns Hopkins Center for Injury Research and ... mortality rate occurred immediately following the 1999 introduction of ... suggesting a major change in the way deaths were ...
Cached Medicine News:Health News:New biomarker test predicts arthritis at much earlier stage, MU researchers say 2Health News:Doctors Restore Some Hand Function to Quadriplegic Patient 2Health News:Doctors Restore Some Hand Function to Quadriplegic Patient 3Health News:FDA Panel to Consider At-Home HIV Test 2Health News:FDA Panel to Consider At-Home HIV Test 3Health News:Study highlights need for coordination of care in stage 2 and 3 rectal cancer treatment 2Health News:Study highlights need for coordination of care in stage 2 and 3 rectal cancer treatment 3Health News:Reported increase in older adult fall deaths due to improved coding 2
... Assisted Lipoplasty Device uses a 2-mm reciprocating movement ... movement of the cannula in tissue. So less ... fibrous tissue. That makes the lipoplasty procedure easier ... your mind to learn that the PAL® is ...
... in.hg.@sea level. Incredibly quiet, yet very powerful. ... systems at one time eliminates the need ... Standard canister set-up is for Abbott 2000ml ... c-UL and CE marks. Includes a wireless ...
... cohesive is a new term being used today to ... more liquid fill that may have been used in ... new science, this is not new technology cohesive ... describe the sticking together nature of the gel. All ...
This Implant enhances and restores the nasal contour, The large selection of sizes with a variety of flares and lengths allows for more individualized results...
Medicine Products: